Zacks Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $177M | Buy |
815,533
+133,200
| +20% | +$29.5M | 1.42% | 15 |
|
|
2025
Q4 | $156M | Sell |
682,333
-105,441
| -13% | -$24M | 1.22% | 17 |
|
|
2025
Q3 | $182M | Sell |
787,774
-32,025
| -4% | -$6.52M | 1.45% | 13 |
|
|
2025
Q2 | $152M | Buy |
819,799
+4,746
| +0.6% | +$882K | 1.3% | 15 |
|
|
2025
Q1 | $171M | Buy |
815,053
+58,192
| +8% | +$11.3M | 1.59% | 12 |
|
|
2024
Q4 | $134M | Sell |
756,861
-96,346
| -11% | -$17.7M | 1.25% | 16 |
|
|
2024
Q3 | $168M | Buy |
853,207
+84,395
| +11% | +$15.8M | 1.46% | 13 |
|
|
2024
Q2 | $132M | Buy |
768,812
+45,526
| +6% | +$7.54M | 1.48% | 15 |
|
|
2024
Q1 | $132M | Buy |
723,286
+86,000
| +13% | +$14.8M | 1.4% | 14 |
|
|
2023
Q4 | $98.8M | Sell |
637,286
-44,228
| -6% | -$6.45M | 1.22% | 19 |
|
|
2023
Q3 | $102M | Buy |
681,514
+1,651
| +0.2% | +$242K | 1.32% | 18 |
|
|
2023
Q2 | $91.6M | Buy |
679,863
+8,081
| +1% | +$1.19M | 1.15% | 21 |
|
|
2023
Q1 | $107M | Buy |
671,782
+19,647
| +3% | +$3M | 1.43% | 15 |
|
|
2022
Q4 | $105M | Buy |
652,135
+28,952
| +5% | +$4.44M | 1.47% | 16 |
|
|
2022
Q3 | $83.6M | Sell |
623,183
-37,266
| -6% | -$5.35M | 1.34% | 15 |
|
|
2022
Q2 | $101M | Buy |
660,449
+36,715
| +6% | +$5.61M | 1.54% | 12 |
|
|
2022
Q1 | $101M | Buy |
623,734
+24,438
| +4% | +$3.55M | 1.4% | 14 |
|
|
2021
Q4 | $81.1M | Buy |
599,296
+45,257
| +8% | +$5.35M | 1.14% | 21 |
|
|
2021
Q3 | $59.8M | Buy |
554,039
+22,781
| +4% | +$2.6M | 0.94% | 29 |
|
|
2021
Q2 | $59.8M | Buy |
531,258
+11,757
| +2% | +$1.32M | 0.97% | 30 |
|
|
2021
Q1 | $56.2M | Sell |
519,501
-15,682
| -3% | -$1.68M | 1% | 25 |
|
|
2020
Q4 | $57.3M | Sell |
535,183
-26,131
| -5% | -$2.51M | 1.06% | 21 |
|
|
2020
Q3 | $49.2M | Sell |
561,314
-21,527
| -4% | -$2.03M | 1% | 30 |
|
|
2020
Q2 | $57.2M | Buy |
582,841
+118,031
| +25% | +$10.4M | 1.26% | 20 |
|
|
2020
Q1 | $35.4M | Buy |
464,810
+18,537
| +4% | +$1.58M | 0.87% | 42 |
|
|
2019
Q4 | $39.5M | Buy |
446,273
+3,594
| +0.8% | +$298K | 0.74% | 48 |
|
|
2019
Q3 | $33.5M | Buy |
442,679
+10,440
| +2% | +$716K | 0.67% | 49 |
|
|
2019
Q2 | $31.4M | Buy |
432,239
+20,378
| +5% | +$1.6M | 0.64% | 51 |
|
|
2019
Q1 | $33.2M | Sell |
411,861
-4,351
| -1% | -$356K | 0.71% | 48 |
|
|
2018
Q4 | $38.4M | Sell |
416,212
-7,140
| -2% | -$628K | 0.93% | 33 |
|
|
2018
Q3 | $40M | Sell |
423,352
-1,170
| -0.3% | -$111K | 0.84% | 39 |
|
|
2018
Q2 | $39.3M | Buy |
424,522
+4,929
| +1% | +$481K | 0.86% | 35 |
|
|
2018
Q1 | $39.7M | Sell |
419,593
-166,381
| -28% | -$18.3M | 0.88% | 34 |
|
|
2017
Q4 | $56.7M | Buy |
585,974
+7,282
| +1% | +$686K | 1.24% | 21 |
|
|
2017
Q3 | $51.4M | Buy |
578,692
+3,944
| +0.7% | +$300K | 1.2% | 22 |
|
|
2017
Q2 | $41.7M | Buy |
574,748
+9,771
| +2% | +$657K | 1.03% | 28 |
|
|
2017
Q1 | $36.8M | Buy |
564,977
+37,745
| +7% | +$2.37M | 0.94% | 31 |
|
|
2016
Q4 | $33M | Buy |
527,232
+14,076
| +3% | +$859K | 0.95% | 29 |
|
|
2016
Q3 | $32.4M | Buy |
513,156
+43,845
| +9% | +$2.84M | 0.92% | 31 |
|
|
2016
Q2 | $29.1M | Buy |
469,311
+12,608
| +3% | +$768K | 0.89% | 29 |
|
|
2016
Q1 | $26.1M | Buy |
456,703
+19,056
| +4% | +$1.06M | 0.83% | 32 |
|
|
2015
Q4 | $25.9M | Sell |
437,647
-11,192
| -2% | -$645K | 0.85% | 36 |
|
|
2015
Q3 | $24.4M | Sell |
448,839
-12,859
| -3% | -$837K | 0.85% | 35 |
|
|
2015
Q2 | $31M | Sell |
461,698
-48,595
| -10% | -$3.17M | 0.98% | 26 |
|
|
2015
Q1 | $29.9M | Buy |
510,293
+20,625
| +4% | +$1.25M | 0.95% | 28 |
|
|
2014
Q4 | $32M | Buy |
489,668
+27,822
| +6% | +$1.75M | 1.04% | 26 |
|
|
2014
Q3 | $26.6M | Buy |
461,846
+29,687
| +7% | +$1.65M | 0.93% | 28 |
|
|
2014
Q2 | $24.4M | Buy |
432,159
+20,290
| +5% | +$1.06M | 0.87% | 30 |
|
|
2014
Q1 | $21.2M | Buy |
411,869
+30,086
| +8% | +$1.52M | 0.78% | 32 |
|
|
2013
Q4 | $20.2M | Buy |
381,783
+223,176
| +141% | +$11M | 0.8% | 28 |
|
|
2013
Q3 | $7.09M | Buy |
158,607
+15,985
| +11% | +$709K | 0.31% | 123 |
|
|
2013
Q2 | $5.9M | Buy |
+142,622
| New | +$6.24M | 0.27% | 131 |
|
Other funds holding ABBV
VCM
VPM
Zacks Investment Management's ABBV Position: Q1 2026 in Review
Zacks Investment Management increased its AbbVie (ABBV) stake by 20% in Q1 2026, buying an estimated $29.5M and bringing the position to 815,533 shares worth $177M. The position accounts for 1.42% of the portfolio, ranked #15.
Zacks Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $182M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Zacks Investment Management held 815,533 shares of AbbVie worth $177M as of Q1 2026.
- Zacks Investment Management bought 133,200 AbbVie shares in Q1 2026, an estimated $29.5M.
- AbbVie made up 1.42% of Zacks Investment Management's portfolio in Q1 2026, its #15 holding.
- Zacks Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Zacks Investment Management's AbbVie position peaked at $182M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.